VOYA Investment Management
SCPH

VOYA Investment Management’s scPharmaceuticals SCPH Stock Holding History

VOYA Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,954
Closed -$41.7K – 2620
2025
Q2 		$41.7K Buy
+10,954
New +$34K ﹤0.01% 2625
2024
Q4 		– Sell
-11,389
Closed -$51.9K – 2789
2024
Q3 		$51.9K Sell
11,389
-112
-1% -$542 ﹤0.01% 2769
2024
Q2 		$50K Buy
+11,501
New +$50.5K ﹤0.01% 2793
2024
Q1 		– Sell
-11,752
Closed -$73.7K – 2868
2023
Q4 		$73.7K Hold
11,752
– – ﹤0.01% 2805
2023
Q3 		$83.7K Hold
11,752
– – ﹤0.01% 2773
2023
Q2 		$120K Buy
+11,752
New +$123K ﹤0.01% 2736

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

VOYA Investment Management's SCPH Position: Q3 2025 in Review

VOYA Investment Management sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 10,954 shares — an estimated $41.7K sold.

VOYA Investment Management first reported a position in SCPH in Q2 2023 and held it in 6 quarters. The position peaked at $120K in Q2 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

  • VOYA Investment Management reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 10,954 scPharmaceuticals shares in Q3 2025, an estimated $41.7K.
  • VOYA Investment Management first reported a position in scPharmaceuticals in Q2 2023 and held it in 6 quarters.
  • VOYA Investment Management's scPharmaceuticals position peaked at $120K in Q2 2023.
  • 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.